Skip to main content
Clinical Trials/CTRI/2023/09/057296
CTRI/2023/09/057296
Not yet recruiting
Phase 3

Clinical and radiographic evaluation of injectable platelet rich fibrin polymerization with hydroxyapatite bone graft in the treatment of grade ii furcation defects- a randomized controlled clinical study. - NI

TEPARAMESWARI0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
TEPARAMESWARI
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
TEPARAMESWARI

Eligibility Criteria

Inclusion Criteria

  • Clinical evidence of buccal furcation defect \= 3 mm measured using Naber’s probe.
  • Vertical probing depth \=5mm measured using unc\-15 probe.
  • radiographic evidence of furcation defect.

Exclusion Criteria

  • Systemic diseases.
  • Pregnant and lactating women.
  • Grade\-III mobility.
  • Teeth with incorrect endodontic treatment or restorative treatment.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 3
A clinical trial to study the effects of mumps-measles-rubella vaccine in improving patients with multiple warts in skiHealth Condition 1: null- Multiple Cutaneous Warts
CTRI/2017/10/010021Dr Prof Shyam Sundar Chaudhary
Active, not recruiting
Phase 1
Study with hzVSF-v13 in patients with COVID-19 pneumonia: a phase II, proof of concept, multicentre, randomized, parallel-group, double-blind, placebo-controlled studyModerate-to-severe COVID-19 pneumoniaMedDRA version: 23.0Level: LLTClassification code 10053983Term: Corona virus infectionSystem Organ Class: 100000004862Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
EUCTR2020-003614-13-ITImmuneMed Inc.105
Active, not recruiting
Not Applicable
Study of the macrocopic and microscopic distribution (after theintravenous injection) of one fluorescent marker (the Indocyanine Green)at the level of the mammary tumour, the axillary lymph nodes and thenormal mammary tissues of patients operated (mastectomy with completeaxillary node dissection) for breast carcinomabreast cancerTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Investigative Techniques [E05]
EUCTR2013-000100-41-BEJules Bordet Institute
Recruiting
Phase 3
Comparison of the therapeutic effect of injectable pantoprazole and famotidine in patients with epigastric pai
IRCT20230614058478N1Zahedan University of Medical Sciences80
Completed
Phase 3
evaluation of applying Plasma rich growth factor(PRGF) with Metformin gel 1% in treating periodontal intrabony defects
IRCT20100427003813N6Babol University of Medical Sciences24